Anebulo Pharmaceuticals (FRA:214) Accounts Payable & Accrued Expense : €0.93 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Anebulo Pharmaceuticals Accounts Payable & Accrued Expense?

Anebulo Pharmaceuticals's quarterly accounts payable & accrued expense increased from Sep. 2023 (€0.67 Mil) to Dec. 2023 (€0.93 Mil) but then declined from Dec. 2023 (€0.93 Mil) to Mar. 2024 (€0.93 Mil).

Anebulo Pharmaceuticals's annual accounts payable & accrued expense increased from Jun. 2021 (€0.20 Mil) to Jun. 2022 (€0.49 Mil) and increased from Jun. 2022 (€0.49 Mil) to Jun. 2023 (€0.99 Mil).

Anebulo Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Anebulo Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anebulo Pharmaceuticals Accounts Payable & Accrued Expense Chart

Anebulo Pharmaceuticals Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

0.02

0.20

0.49

0.99

Anebulo Pharmaceuticals Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial										1.39	0.99	0.67	0.93	0.93

Anebulo Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Anebulo Pharmaceuticals (FRA:214) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anebulo Pharmaceuticals Inc (FRA:214) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ANEB:USA

Address

1017 Ranch Road 620 South, Suite 107, Lakeway, TX, USA, 78734

Website

https://www.anebulo.com

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Anebulo Pharmaceuticals (FRA:214) Headlines

No Headlines